This finding is in keeping with recent reports in which high levels of CD49d mRNA and protein were found to be part of the signature distinguishing CD38+ from CD38- B-CLL cells [51,52]. This evidence concerns the gene ITGA4 and B-cell chronic lymphocytic leukemia.